Clarify Health vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 72)
Clarify Health logo

Clarify Health

LeaderHealthcare

Healthcare Analytics & Value-Based Care

Clarify Health is an AI-powered healthcare analytics platform serving health plans, providers, and life sciences — raised $150M+ total, acquired Apervita in 2024 to expand value-based care analytics.

AI VisibilityBeta
Overall Score
B72
Category Rank
#118 of 596
AI Consensus
72%
Trend
stable
Per Platform
ChatGPT
66
Perplexity
67
Gemini
73

About

Clarify Health is a San Francisco-based cloud analytics company that provides AI-powered performance measurement, benchmarking, and market intelligence to health plans, health systems, and life sciences companies. Its flagship platform, Clarify Atlas, aggregates and analyzes longitudinal patient journey data to deliver insights into provider performance, market dynamics, price transparency, referral patterns, and care quality — enabling payers and providers to manage value-based care arrangements and identify opportunities to improve outcomes while reducing costs.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

72
Overall Score
90
#118
Category Rank
#2
72
AI Consensus
83
stable
Trend
stable
66
ChatGPT
92
67
Perplexity
93
73
Gemini
89
77
Claude
96
68
Grok
95

Key Details

Category
Healthcare Analytics & Value-Based Care
Enterprise
Tier
Leader
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.